Pedro, S.N.; Mendes, M.S.M.; Neves, B.M.; Almeida, I.F.; Costa, P.; Correia-Sá, I.; Vilela, C.; Freire, M.G.; Silvestre, A.J.D.; Freire, C.S.R.
Deep Eutectic Solvent Formulations and Alginate-Based Hydrogels as a New Partnership for the Transdermal Administration of Anti-Inflammatory Drugs. Pharmaceutics 2022, 14, 827.
https://doi.org/10.3390/pharmaceutics14040827
AMA Style
Pedro SN, Mendes MSM, Neves BM, Almeida IF, Costa P, Correia-Sá I, Vilela C, Freire MG, Silvestre AJD, Freire CSR.
Deep Eutectic Solvent Formulations and Alginate-Based Hydrogels as a New Partnership for the Transdermal Administration of Anti-Inflammatory Drugs. Pharmaceutics. 2022; 14(4):827.
https://doi.org/10.3390/pharmaceutics14040827
Chicago/Turabian Style
Pedro, Sónia N., Maria S. M. Mendes, Bruno M. Neves, Isabel Filipa Almeida, Paulo Costa, Inês Correia-Sá, Carla Vilela, Mara G. Freire, Armando J. D. Silvestre, and Carmen S. R. Freire.
2022. "Deep Eutectic Solvent Formulations and Alginate-Based Hydrogels as a New Partnership for the Transdermal Administration of Anti-Inflammatory Drugs" Pharmaceutics 14, no. 4: 827.
https://doi.org/10.3390/pharmaceutics14040827
APA Style
Pedro, S. N., Mendes, M. S. M., Neves, B. M., Almeida, I. F., Costa, P., Correia-Sá, I., Vilela, C., Freire, M. G., Silvestre, A. J. D., & Freire, C. S. R.
(2022). Deep Eutectic Solvent Formulations and Alginate-Based Hydrogels as a New Partnership for the Transdermal Administration of Anti-Inflammatory Drugs. Pharmaceutics, 14(4), 827.
https://doi.org/10.3390/pharmaceutics14040827
